federal_register: 2011-24431

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2011-24431 Guidance for Industry on Reproductive and Developmental Toxicities-Integrating Study Results To Assess Concerns; Availability Notice The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Reproductive and Developmental Toxicities--Integrating Study Results to Assess Concerns." This guidance describes an approach to estimating possible human developmental or reproductive risks associated with drug or biological product exposure when a nonclinical finding of toxicity has been identified, but definitive human data are unavailable. The guidance is intended for drug developers planning to submit new drug applications (NDAs) and biologics licensing applications (BLAs), and who are assessing nonclinical toxicity information. 2011-09-23 2011 9 https://www.federalregister.gov/documents/2011/09/23/2011-24431/guidance-for-industry-on-reproductive-and-developmental-toxicities-integrating-study-results-to https://www.govinfo.gov/content/pkg/FR-2011-09-23/pdf/2011-24431.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Reproductive and Developmental Toxicities--Integrating Study Results to Assess Concerns." This guidance describes an approach to estimating...

Links from other tables